| Product Code: ETC14725786 | Publication Date: Jun 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Biopharma Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Biopharma Market Revenues & Volume, 2022 & 2032F |
3.3 Thailand Biopharma Market - Industry Life Cycle |
3.4 Thailand Biopharma Market - Porter's Five Forces |
3.5 Thailand Biopharma Market Revenues & Volume Share, By Segment, 2022 & 2032F |
3.6 Thailand Biopharma Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.7 Thailand Biopharma Market Revenues & Volume Share, By Therapeutic Area, 2022 & 2032F |
3.8 Thailand Biopharma Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
3.9 Thailand Biopharma Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Thailand Biopharma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand Biopharma Market Trends |
6 Thailand Biopharma Market, By Types |
6.1 Thailand Biopharma Market, By Segment |
6.1.1 Overview and Analysis |
6.1.2 Thailand Biopharma Market Revenues & Volume, By Segment, 2022 - 2032F |
6.1.3 Thailand Biopharma Market Revenues & Volume, By Biologics, 2022 - 2032F |
6.1.4 Thailand Biopharma Market Revenues & Volume, By Biosimilars, 2022 - 2032F |
6.1.5 Thailand Biopharma Market Revenues & Volume, By Vaccines, 2022 - 2032F |
6.1.6 Thailand Biopharma Market Revenues & Volume, By Cell & Gene Therapies, 2022 - 2032F |
6.2 Thailand Biopharma Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Biopharma Market Revenues & Volume, By Monoclonal Antibodies, 2022 - 2032F |
6.2.3 Thailand Biopharma Market Revenues & Volume, By Erythropoietins, 2022 - 2032F |
6.2.4 Thailand Biopharma Market Revenues & Volume, By DNA-based, 2022 - 2032F |
6.2.5 Thailand Biopharma Market Revenues & Volume, By Engineered Cells, 2022 - 2032F |
6.3 Thailand Biopharma Market, By Therapeutic Area |
6.3.1 Overview and Analysis |
6.3.2 Thailand Biopharma Market Revenues & Volume, By Oncology, 2022 - 2032F |
6.3.3 Thailand Biopharma Market Revenues & Volume, By Immunology, 2022 - 2032F |
6.3.4 Thailand Biopharma Market Revenues & Volume, By Infectious Diseases, 2022 - 2032F |
6.3.5 Thailand Biopharma Market Revenues & Volume, By Rare Diseases, 2022 - 2032F |
6.4 Thailand Biopharma Market, By Drug Class |
6.4.1 Overview and Analysis |
6.4.2 Thailand Biopharma Market Revenues & Volume, By Protein-based, 2022 - 2032F |
6.4.3 Thailand Biopharma Market Revenues & Volume, By Recombinant, 2022 - 2032F |
6.4.4 Thailand Biopharma Market Revenues & Volume, By mRNA, 2022 - 2032F |
6.4.5 Thailand Biopharma Market Revenues & Volume, By Viral Vectors, 2022 - 2032F |
6.5 Thailand Biopharma Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Thailand Biopharma Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.5.3 Thailand Biopharma Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.5.4 Thailand Biopharma Market Revenues & Volume, By Public Health Agencies, 2022 - 2032F |
6.5.5 Thailand Biopharma Market Revenues & Volume, By Biopharma Firms, 2022 - 2032F |
7 Thailand Biopharma Market Import-Export Trade Statistics |
7.1 Thailand Biopharma Market Export to Major Countries |
7.2 Thailand Biopharma Market Imports from Major Countries |
8 Thailand Biopharma Market Key Performance Indicators |
9 Thailand Biopharma Market - Opportunity Assessment |
9.1 Thailand Biopharma Market Opportunity Assessment, By Segment, 2022 & 2032F |
9.2 Thailand Biopharma Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.3 Thailand Biopharma Market Opportunity Assessment, By Therapeutic Area, 2022 & 2032F |
9.4 Thailand Biopharma Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
9.5 Thailand Biopharma Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Thailand Biopharma Market - Competitive Landscape |
10.1 Thailand Biopharma Market Revenue Share, By Companies, 2025 |
10.2 Thailand Biopharma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here